The direct medical costs of undiagnosed chronic obstructive pulmonary disease

Value in Health

Volumn 11, Issue 4, 2008, Pages 628-636

  Mapel, Douglas W ^a   Robinson, Scott B ^a   Dastani, Homa B ^b   Shah, Hemal ^b   Phillips, Amy L ^b   Lydick, Eva ^a  

^a LOVELACE CLINIC FOUNDATION   (United States)

^b BOEHRINGER INGELHEIM PHARMACEUTICALS INC   (United States)

Author keywords

Burden of illness; COPD; Epidemiology; Health care costs; Health care utilization

Indexed keywords

ADULT; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DIAGNOSTIC ERROR; DRUG COST; FEMALE; HEALTH CARE COST; HEALTH CARE UTILIZATION; HOSPITALIZATION; HUMAN; INTEGRATED HEALTH CARE SYSTEM; MAJOR CLINICAL STUDY; MALE; MANAGED CARE; OUTPATIENT; PRIORITY JOURNAL;

EID: 47749146990     PISSN: 10983015     EISSN: 15244733     Source Type: Journal    
DOI: 10.1111/j.1524-4733.2007.00305.x     Document Type: Article

References (20)

1. Mannino DM. Chronic obstructive pulmonary disease surveillance - United States, 1971-2000. MMWR Surveill Summ 2002 51 : 1 16.
2. Gulsvik A. The global burden and impact of chronic obstructive pulmonary disease worldwide. Monaldi Arch Chest Dis 2001 56 : 261 4.
3. Mannino DM, Gagnon RC, Petty TL, Lydick E. Obstructive lung disease and low lung function in adults in the United States: data from the National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med 2000 160 : 1683 9.
4. Coultas DB, Mapel D, Gagnon R, Lydick E. The health impact of undiagnosed airflow obstruction in a national sample of United States adults. Am J Respir Crit Care Med 2001 164 : 372 7.
5. Mapel DW, Hurley JS, Frost FJ, et al. Health care utilization in chronic obstructive pulmonary disease: a case-controlled study in a health maintenance organization. Arch Intern Med 2000 160 : 2653 8.
6. Mapel DW, Frost FJ, Hurley JS, et al. An algorithm for the identification of undiagnosed COPD cases based on health care utilization data. J Manag Care Pharm 2006 12 : 458 65.
7. Mapel DW, Picchi MA, Hurley JS, et al. Utilization in chronic obstructive pulmonary disease: patient characteristics and diagnostic evaluation. Chest 2000 117 (Suppl. S346 53.
8. Mapel DW, McMillan GP, Frost FJ, et al. Predicting the costs of managing patients with chronic obstructive pulmonary disease. Respir Med 2005 99 : 1325 33.
9. Department of Health and Human Services, Centers for Medicare and Medicaid Services. Changes to the hospital inpatient prospective payment systems and fiscal year 2003 rates. Fed Regist 2003 67 : 49982 50289.
10. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992 45 : 613 19.
11. Petty TL, Weinmann GG. Building a national strategy for the prevention and management of and research in chronic obstructive pulmonary disease. National Heart, Lung, and Blood Institute Workshop summary. JAMA 1997 277 : 246 53.
12. Ferguson GT, Enright PL, Buist AS, et al. Office spirometry for lung health assessment in adults. A consensus statement from the National Lung Health Education Program. Chest 2000 117 : 1146 61.
13. The GOLD Scientific Committee. Global strategy for the diagnosis, management, and prevention of COPD, 2006 Update. Available form: http://www.GOLDCOPD.com [Accessed January 1, 2007].
14. Hilleman DE, Dewan N, Malesker M, Friedman M. Pharmacoeconomic evaluation of COPD. Chest 2000 118 : 1278 85.
15. National Heart, Lung, and Blood Institute. Morbidity and Mortality: 2004 Chart Book on Cardiovascular, Lung, and Blood Diseases. Bethesda, MD : National Heart, Lung, and Blood Institute, 2004. Available from: http://www.nhlbi.nih. gov/resources/docs/cht-book.htm [Accessed December 9, 2007].
16. Leigh JP, Romano PS, Schenker MB, Kreiss K. Costs of occupational COPD and asthma. Chest 2002 121 : 264 72.
17. Ward MM, Javitz HS, Smith WM, Bakst A. Direct medical costs of chronic obstructive pulmonary disease in the U.S.A. Respir Med 2000 94 : 1123 9.
18. Marton JP, Boulanger L, Friedman M, et al. Assessing the costs of chronic obstructive pulmonary disease: the state Medicaid perspective. Respir Med 2005 100 : 996 1005.
19. Miller JD, Foster T, Boulanger L, et al. Direct costs of COPD in the U.S.: An analysis of Medical Expenditure Panel Survey (MEPS) Data. COPD 2005 2 : 311 18.
20. Stuart B, Doshi JA, Briesacher B, et al. Impact of prescription coverage on hospital and physician costs: a case study of Medicare beneficiaries with chronic obstructive pulmonary disease. Clin Ther 2004 26 : 1688 99.